Health Science Policy Council Chair 2019 - 2021
Shelby Reed, RPh, PhD
Professor, Duke Clinical Research Institute
Durham, NC, United States
Health Science Policy Council Members
Policy Outlook Committee
Ola Ahmad Al Ahdab, RPh, PhD, BSc
Dr
Abu Dhabi, AZ, United Arab Emirates
Pamela Blumberg, DrPH, MPH
VP Value & Access, TriNetX
Cambridge, SC, United States
Lou Garrison, PhD
Professor Emeritus, The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute,
Seattle, WA, United States
Jorge Gómez, MSc, PhD
Senior HE Manager for Vaccines LATAM, GlaxoSmithKline
Victoria, B, Argentina
Jens Grueger, PhD
Director and Partner, Boston Consulting Group
Freiburg, BW, Germany
Finn Børlum Kristensen, PhD, MD
Danish Centre for Health Economics - University of Southern Denmark
Hilleroed, 84, Denmark
Eui-Kyung Lee, RPh, PhD
sungkyunkwan university
Taipei, Taiwan
Newell McElwee, PharmD, MSPH
Vice President HEOR, Boehringer Ingleheim
Ridgefield, CT, United States
Maciej Niewada, MSc, PhD, MD, MA
Professor, ISPOR Poland Chapter
Warsaw, MZ, Poland
Brian O'Rourke, PharmD
Retired Health Care Executive
Ottawa, ON, Canada
Chris Pashos, BS, PhD, MPP
Advisor / consultant, Genesis Research
Winchester, MA, United States
Soualmi Redouane, MSc, PharmD
Head of Market Access & Government Affairs, Boehringer Ingelheim
Ouled Fayet, 16, Algeria
Suzanne Schrandt, JD
Founder, CEO, & Chief Patient Advocate, ExPPect
Washington, DC, United States
Adrian Towse, Mphil, MA
Emeritus Director, Office of Health Economics
London, United Kingdom
Science/Research Committee
Ibrahim Alabbadi, MBA, RPh, PhD, DrPH, BSc
Professor, The University of Jordan
Amman, AM, Jordan
Michael Drummond, PhD
Professor of Health Economics, University of York
York, YOR, United Kingdom
Ana Lucia Hincapie, MSc, PhD
Assistant Professor, University of Cincinnati College of Pharmacy
Cincinatti, OH, United States
Rok Hren, MSc, PhD, BSc
Director, Hren & Partner d.o.o.
Ljubljana, Slovenia
Maarten IJzerman, MSc, PhD
Chair of Cancer Health Services Research, University of Melbourne and University of Twente
Melbourne, VIC, Australia
Khalid Kamal, MS, PhD
Professor, West Virginia University
Morgantown, WV, United States
Paul Kind
Professor, University of Leeds
Leeds, United Kingdom
Vivian Lee, PharmD, BSc
Associate Professor, The Chinese University of Hong Kong
Shatin, Hong Kong
Josephine Mauskopf, PhD
Vice President, Health Economics, RTI Health Solutions
Research Triangle Park, NC, United States
Karen Rascati, RPh, PhD
Professor, University of Texas College of Pharmacy
Austin, TX, United States
Shelby Reed, RPh, PhD
Professor, Duke Clinical Research Institute
Durham, NC, United States
Mark Sculpher, MSc, PhD, BA
University of York
York, NYK, United Kingdom
Marthinus Stander, MBA, MD
Managing Director, VI Research FZ-LLC
Dubai, DU, United Arab Emirates
Task Force Review Committee
Federico Augustovski, MSc, PhD, MD
Director, HTA, (IECS) Institute for Clinical Effectiveness and Health Policy
Buenos Aires, Argentina
Marc Berger, MD
Marc L. Berger, LLC
New York, NY, United States
Reed Johnson, PhD
Professor, Duke School of Medicine, Duke Clinical Research Institute
Durham, NC, United States
C. Daniel Mullins, PhD
University of Maryland Baltimore
Baltimore, MD, United States
Donald Patrick, PhD, MSPH
Professor Emeritus, University of Washington
Seattle, WA, United States
Scott Ramsey, PhD, MD
Full Member & Co-Director, Fred Hutchinson Cancer Research Center
Seattle, WA, United States
Mark S. Roberts, MD, MPP
Professor and Chair, Health Policy and Management, University of Pittsburgh
Pittsburgh, PA, United States